RDIF commented on possible terms of registration of "Sputnik V" in the EU

As noted in the Sputnik V Telegram channel, more than 20 international experts and scientists took part in the meeting.

“RDIF has filed an application for vaccine registration and expects the rolling review process to begin in February.

The decision of the European Medicines Agency to grant registration to Sputnik V will be made based on the results of a series of expert examinations, ”the statement says.

As previously reported, the European regulator EMA held consultations with the developers of Sputnik V.

The agency will prepare a scientific opinion on the drug, and after receiving this document, the developer will be able to prepare an application for authorizing the vaccine on the EU market.